Long-Term Urinary, Sexual, and Rectal Morbidity in Patients Treated with Iodine-125 Prostate Brachytherapy Followed Up for a Minimum of 5 Years
- 28 February 2007
- Vol. 69 (2) , 338-342
- https://doi.org/10.1016/j.urology.2006.10.001
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- INTERMEDIATE TERM BIOCHEMICAL-FREE PROGRESSION AND LOCAL CONTROL FOLLOWING 125 IODINE BRACHYTHERAPY FOR PROSTATE CANCERJournal of Urology, 2005
- Permanent seed implantation for localized adenocarcinoma of the prostateCurrent Urology Reports, 2002
- 10-year biochemical (prostate-specific antigen) control of prostate cancer with 125I brachytherapyInternational Journal of Radiation Oncology*Biology*Physics, 2001
- LONG-TERM TREATMENT RELATED COMPLICATIONS OF BRACHYTHERAPY FOR EARLY PROSTATE CANCER: A SURVEY OF PATIENTS PREVIOUSLY TREATEDPublished by Wolters Kluwer Health ,2001
- PENILE ERECTILE FUNCTION AFTER PERMANENT RADIOACTIVE SEED IMPLANTATION FOR TREATMENT OF PROSTATE CANCERJournal of Urology, 2001
- Postimplant dosimetry for 125I prostate implants: definitions and factors affecting outcomeInternational Journal of Radiation Oncology*Biology*Physics, 2000
- Acute urinary morbidity following I-125 interstitial implantation of the prostate glandRadiation Oncology Investigations, 1998
- A modified technique allowing interactive ultrasound-guided three-dimensional transperineal prostate implantationInternational Journal of Radiation Oncology*Biology*Physics, 1995
- Prostate brachytherapy: Improvements in prostate volume measurements and dose distribution using interactive ultrasound guided implantation and three‐dimensional dosimetryRadiation Oncology Investigations, 1995
- Pelvic complications after definitive treatment of prostate cancer by interstitial or external beam radiationUrology, 1983